BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15650411)

  • 21. C-nociceptor sensitization by isoprostanes is cyclooxygenase dependent.
    Junger H; Sorkin LS
    Brain Res; 2000 Jun; 867(1-2):255-8. PubMed ID: 10837823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular effects of isoprostanes after endothelial damage.
    Sametz W; Prasthofer S; Wintersteiger R; Juan H
    Prostaglandins Leukot Essent Fatty Acids; 1999 Dec; 61(6):369-72. PubMed ID: 10718110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of polyunsaturated fatty acids on vasoconstrictions induced by 8-iso-PGF(2alpha) and 8-iso-PGE(2).
    Sametz W; Jeschek M; Juan H; Wintersteiger R
    Pharmacology; 2000 Apr; 60(3):155-60. PubMed ID: 10754452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction for special forum issue on isoprostanes and related compounds.
    Morrow JD
    Antioxid Redox Signal; 2005; 7(1-2):153-6. PubMed ID: 15650404
    [No Abstract]   [Full Text] [Related]  

  • 25. The isoprostanes: unique bioactive products of lipid peroxidation.
    Morrow JD; Roberts LJ
    Prog Lipid Res; 1997 Mar; 36(1):1-21. PubMed ID: 9373618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The isoprostanes in biology and medicine.
    Praticò D; Lawson JA; Rokach J; FitzGerald GA
    Trends Endocrinol Metab; 2001 Aug; 12(6):243-7. PubMed ID: 11445440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of isoprostanes on ADP-induced platelet aggregation and cyclic AMP-generation in human platelets.
    Leitinger N; Blazek I; Sinzinger H
    Thromb Res; 1997 May; 86(4):337-42. PubMed ID: 9187022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of activator protein-1 by 8-iso-prostaglandin E2 in a thromboxane A2 receptor-dependent and -independent manner.
    Weber TJ; Markillie LM
    Mol Pharmacol; 2003 May; 63(5):1075-81. PubMed ID: 12695536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoprostanes, novel eicosanoids that produce nociception and sensitize rat sensory neurons.
    Evans AR; Junger H; Southall MD; Nicol GD; Sorkin LS; Broome JT; Bailey TW; Vasko MR
    J Pharmacol Exp Ther; 2000 Jun; 293(3):912-20. PubMed ID: 10869392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thromboxane and isoprostanes as inflammatory and vasoactive mediators in black walnut heartwood extract induced equine laminitis.
    Noschka E; Moore JN; Peroni JF; Lewis SJ; Morrow JD; Robertson TP
    Vet Immunol Immunopathol; 2009 Jun; 129(3-4):200-10. PubMed ID: 19111354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
    Morrow JD; Zackert WE; Yang JP; Kurhts EH; Callewaert D; Dworski R; Kanai K; Taber D; Moore K; Oates JA; Roberts LJ
    Anal Biochem; 1999 May; 269(2):326-31. PubMed ID: 10222005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. F2-isoprostanes are not just markers of oxidative stress.
    Comporti M; Signorini C; Arezzini B; Vecchio D; Monaco B; Gardi C
    Free Radic Biol Med; 2008 Feb; 44(3):247-56. PubMed ID: 17997380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of neurotransmitter release from ocular tissues by isoprostanes.
    Opere CA; Ford K; Zhao M; Ohia SE
    Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):697-701. PubMed ID: 19229378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 8-iso-prostaglandin E2 and 8-iso-prostaglandin F2 alpha on the release of noradrenaline from the isolated rat stomach.
    Nakamura K; Okada S; Ono K; Yokotani K
    Eur J Pharmacol; 2003 May; 470(1-2):73-8. PubMed ID: 12787833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes.
    Morrow JD; Minton TA; Mukundan CR; Campbell MD; Zackert WE; Daniel VC; Badr KF; Blair IA; Roberts LJ
    J Biol Chem; 1994 Feb; 269(6):4317-26. PubMed ID: 8307999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence that the E2-isoprostane, 15-E2t-isoprostane (8-iso-prostaglandin E2) is formed in vivo.
    Morrow JD; Scruggs J; Chen Y; Zackert WE; Roberts LJ
    J Lipid Res; 1998 Aug; 39(8):1589-93. PubMed ID: 9717718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects].
    Cracowski JL; Stanke-Labesque F; Bessard G
    Rev Med Interne; 2000 Mar; 21(3):304-7. PubMed ID: 10763198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism.
    Klein T; Neuhaus K; Reutter F; Nüsing RM
    Br J Pharmacol; 2001 Jul; 133(5):643-50. PubMed ID: 11429387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Augmented vasoconstriction and thromboxane formation by 15-F(2t)-isoprostane (8-iso-prostaglandin F(2alpha)) in immature pig periventricular brain microvessels.
    Hou X; Gobeil F; Peri K; Speranza G; Marrache AM; Lachapelle P; Roberts J; Varma DR; Chemtob S; Ellis EF
    Stroke; 2000 Feb; 31(2):516-24; discussion 525. PubMed ID: 10657431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The bronchodilators 8-iso-prostaglandin E2 and prostaglandin E2 induce K+ current suppression via thromboxane A2 receptors in porcine tracheal smooth muscle.
    Helli PB; Catalli A; Janssen LJ
    Eur J Pharmacol; 2004 Oct; 501(1-3):179-84. PubMed ID: 15464076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.